Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cisplatin and Epigallocatechin Gallate

Research Papers that Mention the Interaction

Furthermore, EGCG enhances the efficacy of anti-glioma therapies, including irradiation, temozolomide, carmustine, cisplatin , tamoxifen, and TNF-related apoptosis-inducing ligand, but reduces the effect of bortezomib.
Nutrition and cancer  •  2018  |  View Paper
Our studies also corroborate previous observations that EGCG enhances sensitivity to cisplatin in multiple cancer types.
Using DNA repair assays and clonogenic survival assays, we show that EGCG can inhibit DNA repair and enhance cisplatin sensitivity in human cancer cells.
Nutrients  •  2018  |  View Paper
The green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG), has gained significant attention as a potent adjuvant to enhance the antitumor efficacy of cisplatin while mitigating its harmful side effects.
Biomaterials  •  2017  |  View Paper
EGCG inhibits the rapid degradation of CTR1 induced by cDDP.
In the OVCAR3 ovarian cancer xenograft nude mice model, the combination of the lower concentration of cDDP and EGCG strongly repressed the tumor growth and exhibited protective effect on the nephrotoxicity induced by cisplatin.
The combination of EGCG and cDDP increases the accumulation of cDDP and DNA-Pt adducts, and subsequently enhances the sensitivity of ovarian cancer SKOV3 and OVCAR3 cells to the chemotherapeutic agent.
PloS one  •  2015  |  View Paper
Furthermore, pre-treatment with EGCG followed by DDP caused significant tumor inhibition in vivo.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2015  |  View Paper
As a result, EGCG improved renal function in cisplatin mediated kidney damage.
In addition to that, EGCG attenuated cisplatin induced apoptotic cell death and mitochondrial reactive oxygen species (ROS) generation in human kidney tubular cell line HK-2.
Treatment of mice with EGCG markedly attenuated cisplatin induced mitochondrial oxidative/nitrative stress, mitochondrial damages to electron transport chain activities and antioxidant defense enzyme activities in mitochondria.
PloS one  •  2015  |  View Paper
In addition, the combination treatment of EGCG and cisplatin inhibited tumour formation and induced apoptosis in a xenograft model.
European journal of cancer  •  2013  |  View Paper
EGCG therapy combined with cisplatin led to synergistic inhibition of tumor growth, compared with administration of each treatment separately (P < 0.001).
Chinese journal of natural medicines  •  2013  |  View Paper
EGCG inhibits the rapid degradation of CTR1 induced by cDDP.
In the OVCAR3 ovarian cancer xenograft nude mice model, the combination of the lower concentration of cDDP and EGCG strongly repressed the tumor growth and exhibited protective effect on the nephrotoxicity induced by cisplatin.
The combination of EGCG and cDDP increases the accumulation of cDDP and DNA-Pt adducts, and subsequently enhances the sensitivity of ovarian cancer SKOV3 and OVCAR3 cells to the chemotherapeutic agent.
PloS one  •  2015  |  View Paper
Additionally, EGCG displays a synergistic cytotoxic effect with cisplatin in most tested BTC cell lines.
Combined EGCG and cisplatin treatment showed a synergistic cytotoxic effect in five cell lines and an antagonistic effect in two cell lines.
BMC Complementary and Alternative Medicine  •  2015  |  View Paper
Show More